Alnylam elects Dr. Elliott Sigal to Board, expanding size to 11 members

ALNYLAM PHARMACEUTICALS, INC.

Dr. Sigal elected as Class I director effective Aug 22, 2022; term expires at 2023 annual meeting.
Annual cash fee of $55,000 for non-employee director service.
Initial stock option for 4,456 shares at $217.91/share, $600K grant-date value, vesting over 3 years.
Eligible for annual option award of $400K grant-date value beginning in 2023.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Elliott Sigal

Director

ALNY · ALNYLAM PHARMACEUTICALS, INC.

Effective: 2022-08-22
Filed: August 24, 2022, 7:59 PM ET

Effective as of August 22, 2022, the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company’s Board from ten to eleven and elected Dr. Elliott Sigal to fill the newly created vacancy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Elliott Sigal was elected as Director at ALNYLAM PHARMACEUTICALS, INC..

Action: elected
Role: Director

Exact text from the filing

Effective as of August 22, 2022, the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company’s Board from ten to eleven and elected Dr. Elliott Sigal to fill the newly created vacancy.

View on SEC.gov

ALNYLAM PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-228534

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.